[Good News] Our company has been recognized as a 2023 Provincial “Specialized, Refined, Distinctive, and Innovative” SME.
Release Date:
2023-12-22 16:19
Warm congratulations
66 Vision Tech Co., Ltd. was recognized as a 2023 provincial-level “Specialized, Refined, Distinctive, and Innovative” SME.


On December 14, 2023, the Suzhou Bureau of Industry and Information Technology officially released the list of “Specialized, Refined, Distinctive, and Innovative” SMEs in Jiangsu Province for 2023. The public notice period has now concluded, and 66 Vision Tech Co., Ltd. has been awarded the honor of being a “Specialized, Refined, Distinctive, and Innovative” SME in Jiangsu Province.
“Specialized, Refined, Distinctive, and Innovative” enterprises are characterized by their specialization, refinement, distinctiveness, and innovation. They focus on niche markets, demonstrate strong innovative capabilities, enjoy high market shares, master critical core technologies, and deliver superior quality and performance, positioning themselves as leading players at the forefront of their respective sub‑segments within the industrial chain.
Since its establishment, Liuliu Vision has remained firmly committed to the intelligent manufacturing of ophthalmic medical devices. Drawing on years of industry experience and independent innovation, the company adheres to a development strategy centered on “professionalism, internationalization, cutting-edge technology, high quality, brand building, customer first, and people‑oriented principles,” while striving to strengthen quality management and enhance product performance. To date, the company operates a provincial‑level enterprise technology center and the Jiangsu Provincial Engineering Technology Research Center for Ophthalmic Diagnostic and Therapeutic Devices, and has been honored with numerous accolades, including “Top 50 Chinese Pharmaceutical Companies” and “National High‑Tech Enterprise.” It has also obtained more than thirty patents across various categories.
This recognition as a Jiangsu Province Specialized, Sophisticated, and Novel SME not only underscores the high regard for Liuliu Vision’s comprehensive strengths—including its research capabilities, innovative capacity, and core manufacturing processes—but also injects powerful momentum into the company’s sustained, healthy development. Moving forward, Liuliu Vision will continue to attract cutting-edge talent, steadily enhance its R&D and management practices, ensure the innovation and advanced nature of its technologies, and remain steadfast in upholding its mission of serving ophthalmology and caring for eyes with genuine dedication.
Related News
No Clouds in the Fundus, Light in Old Age | National Eye Care Day & Liuliu Vision’s 69th Anniversary
June 6, 2025, marks the 30th National Eye Care Day. According to the “14th Five-Year Plan for National Eye Health,” the leading causes of blindness in China have shifted to conditions such as cataracts and glaucoma.
“Specialized, Refined, Distinctive, and Innovative” enterprises are characterized by specialization, refinement, distinctiveness, and innovation. They focus on niche markets, demonstrate strong innovation capabilities, enjoy high market shares, master critical core technologies, and deliver superior quality and performance, positioning themselves as industry leaders in their respective segments. Since its inception, Liuliu Vision has remained committed to the intelligent manufacturing of ophthalmic medical devices. Drawing on years of industry experience and independent innovation, the company adheres to a development strategy centered on “professionalism, internationalization, cutting-edge technology, high quality, brand building, customer first, and people-oriented principles,” striving to strengthen quality management and enhance product performance. To date, the company operates a provincial-level enterprise technology center and the Jiangsu Provincial Engineering Technology Research Center for Ophthalmic Diagnostic and Therapeutic Devices, and has earned numerous accolades, including being recognized among China’s Top 50 Pharmaceutical Companies and designated as a National High-Tech Enterprise. It has also obtained more than thirty patents across various categories. Being certified this time as a specialized, refined, distinctive, and innovative small and medium-sized enterprise in Jiangsu Province not only underscores Liuliu Vision’s comprehensive strengths—its research capabilities, innovative capacity, and core manufacturing processes—but also provides a powerful impetus for the company’s sustained, healthy growth. Moving forward, Liuliu Vision will continue to attract top-tier technical talent, further elevate its R&D and management standards, ensure technological innovation and cutting-edge advancement, and steadfastly uphold its mission of serving the ophthalmology field with genuine care for eye health.
Our company will be exhibiting at the 22nd Shanghai International Ophthalmology and Optometry Technology & Equipment Exhibition, held from December 9 to 11, 2022, at the Shanghai International Procurement Fair. We warmly welcome both new and longstanding friends to visit!
[Exhibition Notice] 21st China International Eyewear Exhibition
Our company will be exhibiting at the 21st China International Eyewear Exhibition, held in 2022 at the Suzhou International Expo Center. We warmly welcome both new and longstanding friends to visit!
[Exhibition Notice] The 26th National Ophthalmology Conference
Our company will be participating in the 26th National Ophthalmology Conference, to be held from December 14 to 17, 2022, at the China West International Expo City in Chengdu. We warmly welcome both new and longstanding friends to attend!